Henry Schein Inc. (HSIC) News
Filter HSIC News Items
HSIC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HSIC News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest HSIC News From Around the Web
Below are the latest news stories about HENRY SCHEIN INC that investors may wish to consider to help them evaluate HSIC as an investment opportunity.
Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresMELVILLE, N.Y., January 09, 2025--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires. |
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA AnalystBofA Securities predicts that headline risks affecting the Healthcare Tech & Distribution sector in 2024 will likely continue in 2025. Key areas of concern include pharmacy benefit managers (PBMs), retail pharmacies, distributors, fertility benefits, and direct-to-consumer (D2C) pharmacies. While regulatory pressure on PBMs is expected to persist, the analyst believes this will mainly impact profit margins and growth rates rather than lead to major changes in the business model. Potential policy |
Henry Schein Stock to Gain From New Acquisitions Amid Macro WoesHenry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency. |
Why This 1 Value Stock Could Be a Great Addition to Your PortfolioWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
The Celebrity Activist Investor Is Going ExtinctAn era of big-name activists with fiery personalities waging noisy proxy battles and wielding brash tactics to win board seats is over. Carl Icahn, facing attacks on how he manages his own publicly traded firm, has slowed his fire. Nelson Peltz, fresh off losing a battle with Disney is planning to hand his firm to his less pugnacious son and others. |
Should You Retain Henry Schein Stock in Your Portfolio Right Now?Investors are optimistic about HSIC owing to the performance of its dental business. |
Is Henry Schein, Inc. (NASDAQ:HSIC) Potentially Undervalued?Henry Schein, Inc. ( NASDAQ:HSIC ), might not be a large cap stock, but it saw significant share price movement during... |
Henry Schein to Participate at J.P. Morgan’s Healthcare Investor ConferenceMELVILLE, N.Y., December 17, 2024--Henry Schein to participate at J.P. Morgan's Healthcare Investor Conference. |
Here's Why Henry Schein (HSIC) is a Strong Value StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator |